ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Survival with malignant pleural effusions according to cancer type

Survival with malignant pleural effusions according to cancer type
Cell type Median survival in days (95% CI) n
Mesothelioma 339 (267 to 422) 170
Hematological malignancy 218 (160 to 484) 35
Gynecological malignancy 230 (97 to 279) 59
Breast cancer 192 (133 to 271) 140
Renal cell carcinoma 114 (33 to 334) 22
Adenocarcinoma of unknown primary 87 (13 to 286) 11
Lung cancer 74 (60 to 92) 215
Other 71 (46 to 102) 33
Gastrointestinal cancer 61 (44 to 73) 61
Sarcoma 44 (19 to 76) 12
Melanoma 43 (23 to 72) 23
Urological cancer (bladder, prostate, testis, penile) 33 (22 to 168) 8
Overall 136 (119 to 167) 789
Reproduced with permission from: Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 2014; 69:1098-1104. Copyright © 2014 BMJ Publishing Group Ltd.
Graphic 116821 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟